Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients
View ORCID ProfileCong Zeng, John P. Evans, Sarah Reisinger, Jennifer Woyach, Christina Liscynesky, Zeinab El Boghdadly, Mark P. Rubinstein, Karthik Chakravarthy, Linda Saif, Eugene M. Oltz, Richard J. Gumina, Peter G. Shields, Zihai Li, View ORCID ProfileShan-Lu Liu
doi: https://doi.org/10.1101/2021.10.20.21265273
Cong Zeng
1Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA
2Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA
John P. Evans
1Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA
2Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA
3Molecular, Cellular and Developmental Biology Program, The Ohio State University, Columbus, OH 43210, USA
Sarah Reisinger
4Comprehensive Cancer Center, James Cancer Hospital, The Ohio State University, Columbus, OH 43210, USA
Jennifer Woyach
5Division of Hematology, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA
Christina Liscynesky
6Internal Medicine, Division of Infectious Diseases, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA
Zeinab El Boghdadly
6Internal Medicine, Division of Infectious Diseases, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA
Mark P. Rubinstein
7Division of Medical Oncology, Department of Internal Medicine, Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH43210, USA
Karthik Chakravarthy
7Division of Medical Oncology, Department of Internal Medicine, Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH43210, USA
Linda Saif
8Center for Food Animal Health, Animal Sciences Department, OARDC, College of Food, Agricultural and Environmental Sciences, Wooster, OH 44691, USA
9Veterinary Preventive Medicine Department, College of Veterinary Medicine, The Ohio State University, Wooster, OH 44691, USA
10Viruses and Emerging Pathogens Program, Infectious Diseases Institute, The Ohio State University, Columbus, OH 43210, USA
Eugene M. Oltz
11Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA
Richard J. Gumina
12Department of Medicine, The Ohio State University, Columbus, OH 43210, USA
Peter G. Shields
4Comprehensive Cancer Center, James Cancer Hospital, The Ohio State University, Columbus, OH 43210, USA
Zihai Li
7Division of Medical Oncology, Department of Internal Medicine, Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH43210, USA
Shan-Lu Liu
1Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA
2Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA
10Viruses and Emerging Pathogens Program, Infectious Diseases Institute, The Ohio State University, Columbus, OH 43210, USA
11Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted October 21, 2021.
Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients
Cong Zeng, John P. Evans, Sarah Reisinger, Jennifer Woyach, Christina Liscynesky, Zeinab El Boghdadly, Mark P. Rubinstein, Karthik Chakravarthy, Linda Saif, Eugene M. Oltz, Richard J. Gumina, Peter G. Shields, Zihai Li, Shan-Lu Liu
medRxiv 2021.10.20.21265273; doi: https://doi.org/10.1101/2021.10.20.21265273
Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients
Cong Zeng, John P. Evans, Sarah Reisinger, Jennifer Woyach, Christina Liscynesky, Zeinab El Boghdadly, Mark P. Rubinstein, Karthik Chakravarthy, Linda Saif, Eugene M. Oltz, Richard J. Gumina, Peter G. Shields, Zihai Li, Shan-Lu Liu
medRxiv 2021.10.20.21265273; doi: https://doi.org/10.1101/2021.10.20.21265273
Subject Area
Subject Areas
- Addiction Medicine (341)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2624)
- Dermatology (221)
- Emergency Medicine (397)
- Epidemiology (12169)
- Forensic Medicine (10)
- Gastroenterology (755)
- Genetic and Genomic Medicine (4061)
- Geriatric Medicine (384)
- Health Economics (675)
- Health Informatics (2620)
- Health Policy (997)
- Hematology (359)
- HIV/AIDS (843)
- Medical Education (398)
- Medical Ethics (109)
- Nephrology (429)
- Neurology (3829)
- Nursing (209)
- Nutrition (569)
- Oncology (2005)
- Ophthalmology (581)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1107)
- Primary Care Research (447)
- Public and Global Health (6496)
- Radiology and Imaging (1388)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (338)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)